Completed
Monovalent Recombinant COVID19 Vaccine
NCT04453852
- Conditions
- COVID, COVID-19, Coronaviridae Infections, +11 more
- Locations
-
- PARC, Adelaide, South Australia, Australia
Clinical trial condition
Explore clinical trials studying Pneumonia, Viral. Study availability and eligibility vary by location and protocol.
NCT04453852
NCT05236478
NCT04319445
NCT04664309
NCT05258812
NCT04567979
NCT05256524
NCT04357782
NCT05226546
NCT05218265